A novel membrane protein, vanJ, conferring resistance to teicoplanin

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 4, 2012, Pages 1784-1796

  Novotna, Gabriela ^a   Hill, Chris ^a   Vincent, Karen ^a   Liu, Chang ^a   Hong, Hee Jeon ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; RISTOCETIN; TEICOPLANIN; UNCLASSIFIED DRUG; VANCOMYCIN; VANJ PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOSYNTHESIS; CARBOXY TERMINAL SEQUENCE; GENE CLUSTER; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; STREPTOMYCES COELICOLOR;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BLOTTING, WESTERN; CONJUGATION, GENETIC; CULTURE MEDIA; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; GENETIC COMPLEMENTATION TEST; GENETIC VECTORS; GLYCOPEPTIDES; MEMBRANE PROTEINS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; PLASMIDS; PROTOPLASTS; STREPTOMYCES COELICOLOR; STRUCTURE-ACTIVITY RELATIONSHIP; TEICOPLANIN; VANCOMYCIN;

EID: 84863345059     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05869-11     Document Type: Article

References (44)

1. Arthur M, Quintiliani R. 2001. Regulation of VanA-and VanB-type glycopeptide resistance in enterococci. Antimicrob. Agents Chemother. 45:375-381. (Pubitemid 32105270)
2. Arthur M, Molinas C, Courvalin P. 1992. The VanS-VanR twocomponent regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J. Bacteriol. 174:2582-2591.
3. Arthur M, Molinas C, Reynolds P, Courvalin P. 1993. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J. Bacteriol. 175:117-127. (Pubitemid 23016657)
4. Arthur M, Depardieu F, Molinas C, Reynolds P, Courvalin P. 1995. The vanZ gene of Tn1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin. Gene 154:87-92.
5. Arthur M, Depardieu F, Reynolds P, Courvalin P. 1996. Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci. Mol. Microbiol. 21:33-44. (Pubitemid 26233080)
6. Baptista M, Depardieu F, Courvalin P, Arthur M. 1996. Specificity of induction of glycopeptide resistance genes in Enterococcus faecalis. Antimicrob. Agents Chemother. 40:2291-2295. (Pubitemid 26328034)
7. Baptista M, Depardieu F, Reynolds P, Courvalin P, Arthur M. 1997. Mutations leading to increased levels of resistance to glycopeptide antibiotics in VanB-type enterococci. Mol. Microbiol. 25:93-105. (Pubitemid 27316124)
8. Barna JCJ, Williams DH. 1984. The structure and mode of action of glycopeptide antibiotics of the vancomycin group. Annu. Rev. Microbiol. 38:339-357.
9. Beauregard DA, Williams DH, Gwynn MN, Knowles DJC. 1995. Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics. Antimicrob. Agents Chemother. 39:781-785.
10. Bugg TDH, et al. 1991. Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. Biochemistry 30:10408-10415.
11. Chen L, et al. 2003. Vancomycin analogues active against vanA-resistant strains inhibit bacterial transglycosylase without binding substrate. Proc. Natl. Acad. Sci. U. S. A. 100:5658-5663. (Pubitemid 36576864)
12. Cooper MA, Williams DH. 1999. Binding of glycopeptide antibiotics to a model of a vancomycin-resistant bacterium. Chem. Biol. 6:891-899.
13. Dong SD, et al. 2002. The structural basis for induction of VanB resistance. J. Am. Chem. Soc. 124:9064-9065. (Pubitemid 34847663)
14. Eggert US, et al. 2001. Genetic basis for activity differences between vancomycin and glycolipid derivatives of vancomycin. Science 294:361-364. (Pubitemid 32963401)
15. Evers S, Courvalin P. 1996. Regulation of VanB-type vancomycin resistance gene expression by the VanSB-VanRB two-component regulatory system in Enterococcus faecalis V583. J. Bacteriol. 178:1302-1309.
16. Ge M, et al. 1999. Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala. Science 284:507-511. (Pubitemid 29289628)
17. Gregory MA, Till R, Smith MCM. 2003. Integration site for Streptomyces phage φBT1 and development of site-specific integration vectors. J. Bacteriol. 185:5320-5323. (Pubitemid 37021998)
18. Gust B, Challis GL, Fowler K, Kieser T, Chater KF. 2003. PCR-targeted Streptomyces gene replacement identifies a protein domain needed for biosynthesis of the sesquiterpene soil odor geosmin. Proc. Natl. Acad. Sci. U. S. A. 100:1541-1546. (Pubitemid 36254483)
19. Hannun YA, Obeid LM. 2002. The ceramide-centric universe of lipidmediated cell regulation: stress encounters of the lipid kind. J. Biol. Chem. 277:25847-25850. (Pubitemid 34967060)
20. Hayden MK, Trenholme GM, Schultz JE, Sahm DF. 1993. In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate. J. Infect. Dis. 167:1224-1227. (Pubitemid 23115622)
21. Hesketh A, et al. 2011. Genome-wide dynamics of a bacterial response to antibiotics that target the cell envelope. BMC Genomics 12:226.
22. Hong H-J, Hutchings MI, Buttner MJ. 2008. Vancomycin resistance VanRS two-component systems. Adv. Exp. Med. Biol. 631:200-213.
23. Hong H-J, et al. 2004. Characterization of an inducible vancomycin resistance system in Streptomyces coelicolor reveals a novel gene (vanK) required for drug resistance. Mol. Microbiol. 52:1107-1121. (Pubitemid 38916177)
24. Hong H-J, Hutchings MI, Hill L, Buttner MJ. 2005. The role of the novel Fem protein VanK in vancomycin resistance in Streptomyces coelicolor. J. Biol. Chem. 280:13055-13061.
25. Hutchings MI, Hong H-J, Buttner MJ. 2006. The vancomycin resistance VanRS signal transduction system of Streptomyces coelicolor. Mol. Microbiol. 59:923-935.
26. Hutchings MI, Hong H-J, Leibovitz E, Sutcliffe IC, Buttner MJ. 2006. The SigE cell envelope stress signal of Streptomyces coelicolor is influenced by a novel lipoprotein, CseA. J. Bacteriol. 188:7222-7229. (Pubitemid 44547627)
27. Kaberdina AC, Szaflarski W, Nierhaus KH, Moll I. 2009. An unexpected type of ribosomes induced by kasugamycin: a look into ancestral times of protein synthesis? Mol. Cell 33:227-236.
28. Kerns R, et al. 2000. The role of hydrophobic substituents in the biological activity of glycopeptides antibiotics. J. Am. Chem. Soc. 122:12608-12609. (Pubitemid 32049450)
29. Kieser T, Bibb MJ, Buttner MJ, Chater KF, Hopwood DA. 2000. Practical Streptomyces genetics. The John Innes Foundation, Norwich, United Kingdom.
30. Komatsu M, Tsuda M, Omura S, Oikawa H, Ikeda H. 2008. Identification and functional analysis of genes controlling biosynthesis of 2-methylisoborneol. Proc. Natl. Acad. Sci. U. S. A. 105:7422-7427. (Pubitemid 351830033)
31. Koteva K, et al. 2010. A vancomycin photoprobe identifies the histidine kinase VanSsc as a vancomycin receptor. Nat. Chem. Biol. 6:327-329.
32. Loll PJ, Axelsen PH. 2000. The structural biology of molecular recognition by vancomycin. Annu. Rev. Biophys. Biomol. Struct. 29:265-289. (Pubitemid 30599595)
33. Manteca A, Alvarez R, Salazar N, Yagüe P, Sanchez J. 2008. Mycelium differentiation and antibiotic production in submerged cultures of Streptomyces coelicolor. Appl. Environ. Microbiol. 74:3877-3886. (Pubitemid 351874920)
34. O'Hare MD, Reynolds PE. 1992. Novel membrane proteins present in teicoplanin-resistant, vancomycin-sensitive, coagulase-negative Staphylococcus spp. J. Antimicrob. Chemother. 30:753-768. (Pubitemid 23040959)
35. E, is required for normal cell wall structure in Streptomcyes coelicolor A3(2). J. Bacteriol. 181:204-211.
36. Pootoolal J, Neu J, Wright GD. 2002. Glycopeptide antibiotic resistance. Annu. Rev. Pharmacol. Toxicol. 42:381-408. (Pubitemid 34160531)
37. Pootoolal J, et al. 2002. Assembling the glycopeptide antibiotic scaffold: the biosynthesis of A47934 from Streptomyces toyocaensis. Proc. Natl. Acad. Sci. U. S. A. 99:8962-8967. (Pubitemid 34693666)
38. Potekhina NV, Streshinskaya GM, Novitskaya GV, Naumova IB. 1983. Isolation of lipoteichoic acid from Streptomyces levoris. Mikrobiologiia 52:340-343.
39. Rahman O, Dover LG, Sutcliffe IC. 2009. Lipoteichoic acid biosynthesis: two steps forwards, one step sideways? Trends Microbiol. 17:219-225.
40. Rahman O, Cummings SP, Sutcliffe IC. 2009. Phenotypic variation in Streptomyces sp. DSM 40537, a lipoteichoic acid producing actinomycete. Lett. Appl. Microbiol. 48:226-229.
41. Sharman GJ, et al. 1997. The roles of dimerization and membrane anchoring in activity of glycopeptide antibiotics against vancomycinresistant bacteria. J. Am. Chem. Soc. 119:12041-12047. (Pubitemid 28078686)
42. Shlaes DM, et al. 1993. Teicoplanin-resistant Staphylococcus aureus expresses a novel membrane protein and increases expression of penicillin-binding protein 2 complex. Antimicrob. Agents Chemother. 37:2432-2437. (Pubitemid 23324469)
43. Sinha Roy R, et al. 2001. Direct interaction of a vancomycin derivative with bacterial enzymes involved in cell wall biosynthesis. Chem. Biol. 8:1095-1106. (Pubitemid 33119186)
44. Waksman SA, Henrici AT. 1943. The nomenclature and classification of the actinomycetes. J. Bacteriol. 46:337-341.